Literature DB >> 33757899

Bisphosphonates in dentistry: Historical perspectives, adverse effects, and novel applications.

Parish P Sedghizadeh1, Shuting Sun2, Allan C Jones3, Esmat Sodagar4, Philip Cherian2, Casey Chen4, Adam F Junka5, Jeffrey D Neighbors6, Charles E McKenna7, R Graham G Russell8, Frank H Ebetino9.   

Abstract

Studies of the potential role of bisphosphonates in dentistry date back to physical chemical research in the 1960s, and the genesis of the discovery of bisphosphonate pharmacology in part can be linked to some of this work. Since that time, parallel research on the effects of bisphosphonates on bone metabolism continued, while efforts in the dental field included studies of bisphosphonate effects on dental calculus, caries, and alveolar bone loss. While some utility of this drug class in the dental field was identified, leading to their experimental use in various dentrifice formulations and in some dental applications clinically, adverse effects of bisphosphonates in the jaws have also received attention. Most recently, certain bisphosphonates, particularly those with strong bone targeting properties, but limited biochemical effects (low potency bisphosphonates), are being studied as a local remedy for the concerns of adverse effects associated with other more potent members of this drug class. Additionally, low potency bisphosphonate analogs are under study as vectors to target active drugs to the mineral surfaces of the jawbones. These latter efforts have been devised for the prevention and treatment of oral problems, such as infections associated with oral surgery and implants. Advances in the utility and mechanistic understanding of the bisphosphonate class may enable additional oral therapeutic options for the management of multiple aspects of dental health.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bisphosphonate; Bone targeting conjugates; Dentistry; Pyrophosphate

Mesh:

Substances:

Year:  2021        PMID: 33757899      PMCID: PMC8076070          DOI: 10.1016/j.bone.2021.115933

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.626


  102 in total

1.  Mechanisms of calcification: role of collagen, polyphosphates, and phosphatase.

Authors:  H FLEISH; W F NEUMAN
Journal:  Am J Physiol       Date:  1961-06

Review 2.  Infection and medication-related osteonecrosis of the jaw.

Authors:  H Katsarelis; N P Shah; D K Dhariwal; M Pazianas
Journal:  J Dent Res       Date:  2015-02-20       Impact factor: 6.116

Review 3.  Biofilm as a risk factor in implant treatment.

Authors:  Diane M Daubert; Bradley F Weinstein
Journal:  Periodontol 2000       Date:  2019-10       Impact factor: 7.589

Review 4.  Targeting anti-cancer agents to bone using bisphosphonates.

Authors:  Lianping Xing; Frank H Ebetino; Robert K Boeckman; Venkat Srinivasan; Jianguo Tao; Tomi K Sawyer; Jinbo Li; Zhenqiang Yao; Brendan F Boyce
Journal:  Bone       Date:  2020-06-23       Impact factor: 4.398

5.  Design, Synthesis, and Antimicrobial Evaluation of a Novel Bone-Targeting Bisphosphonate-Ciprofloxacin Conjugate for the Treatment of Osteomyelitis Biofilms.

Authors:  Parish P Sedghizadeh; Shuting Sun; Adam F Junka; Eric Richard; Keivan Sadrerafi; Susan Mahabady; Neema Bakhshalian; Natalia Tjokro; Marzenna Bartoszewicz; Monika Oleksy; Patrycja Szymczyk; Mark W Lundy; Jeffrey D Neighbors; R Graham G Russell; Charles E McKenna; Frank H Ebetino
Journal:  J Med Chem       Date:  2017-02-13       Impact factor: 7.446

6.  The topical administration of bisphosphonates in implant surgery: a randomized split-mouth prospective study with a follow-up up to 5 years.

Authors:  Francesco Zuffetti; Tiziano Testori; Matteo Capelli; Maria Cristina Rossi; Massimo Del Fabbro
Journal:  Clin Implant Dent Relat Res       Date:  2013-09-20       Impact factor: 3.932

7.  Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases.

Authors:  Salvatore L Ruggiero; Bhoomi Mehrotra; Tracey J Rosenberg; Stephen L Engroff
Journal:  J Oral Maxillofac Surg       Date:  2004-05       Impact factor: 1.895

8.  Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: an institutional inquiry.

Authors:  Parish P Sedghizadeh; Kyle Stanley; Matthew Caligiuri; Shawn Hofkes; Brad Lowry; Charles F Shuler
Journal:  J Am Dent Assoc       Date:  2009-01       Impact factor: 3.634

9.  American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update.

Authors:  Salvatore L Ruggiero; Thomas B Dodson; John Fantasia; Reginald Goodday; Tara Aghaloo; Bhoomi Mehrotra; Felice O'Ryan
Journal:  J Oral Maxillofac Surg       Date:  2014-05-05       Impact factor: 2.136

Review 10.  Pharmacologic management of metastatic bone disease.

Authors:  Eric Schwartz; Zachery Reichert; Catherine Van Poznak
Journal:  Bone       Date:  2020-11-07       Impact factor: 4.398

View more
  1 in total

Review 1.  Bisphosphonates for delivering drugs to bone.

Authors:  Shuting Sun; Jianguo Tao; Parish P Sedghizadeh; Philip Cherian; Adam F Junka; Esmat Sodagar; Lianping Xing; Robert K Boeckman; Venkatesan Srinivasan; Zhenqiang Yao; Brendan F Boyce; Brea Lipe; Jeffrey D Neighbors; R Graham G Russell; Charles E McKenna; Frank H Ebetino
Journal:  Br J Pharmacol       Date:  2021-04-10       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.